Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Online

Drug Development Phase 2

Learn the factors that drive the design and conduct of phase 2 clinical trials, as well as the activities and functional areas that contribute to a successful phase 2 program.

Continuing Education

ACPEThe Drug Information Association is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education with Commendation. The Drug Information Association designates this educational activity for up to 1.25 contact hours or .125 continuing education units (CEUs). Type of Activity: Application 0286-0000-24-054-H04-P

PMIDIA has been reviewed and approved as a provider of project management training by the Project Management Institute (PMI).
This program offers a maximum of 1.25 professional development unit (PDUs).
PMI #: 2166PZE66W

The PMI Registered Education Provider logo is a registered mark of the Project Management Institute, Inc.

IACETDrug Information Association (DIA) is accredited by the International Accreditors for Continuing Education and Training (IACET) and offers IACET CEUs for its learning events that comply with the ANSI/IACET Continuing Education and Training Standard. IACET is recognized internationally as a standard development organization and accrediting body that promotes quality of continuing education and training.

As an IACET Accredited Provider, DIA offers CEUs for its programs that qualify under the ANSI/IACET Standard. DIA is authorized by IACET to offer .1 CEUs for this program.

Release Date: June 7, 2018

Reviewed and Updated: June 2, 2021

Release Date: May 30, 2024

Expiration Date: May 30, 2027*

*Continuing education credit is available to participants who successfully complete the eLearning program before the expiration date.
NameCredit TypeMax CreditsCEU
Drug Development Phase 2Credit TypeACPEMax Credits1.25CEU0.125
Drug Development Phase 2Credit TypeIACETMax Credits1.25CEU0.100
Drug Development Phase 2Credit TypePMIMax Credits1.25CEU0.000

Statement of Credit:

Statement of Credit and Successful Completion Requirements
To successfully complete this course and receive a statement of credit, you must review at least 90% of the module, achieve a passing score of 80% or better on the post-assessment, and complete the evaluation.

After a module is completed, you will be able to access the module for one year from the date of purchase.

Sign in to My Account to access My Transcripts and request your online credit.

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.